| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/30/2005 | US20050142620 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/30/2005 | US20050142619 monoclonal antibodies that preferentially bind to cell surface proteins of pancreatic cells; medical diagnosis; immunology |
| 06/30/2005 | US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis |
| 06/30/2005 | US20050142615 Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection |
| 06/30/2005 | US20050142614 Methods for ligand discovery |
| 06/30/2005 | US20050142612 Inhibitors of amyloid precursor protein processing |
| 06/30/2005 | US20050142611 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 06/30/2005 | US20050142610 domains peptides having increased or decreased binding specificity for phosphatides, used as controls in bioassays to detect the presence of specific phosphatides |
| 06/30/2005 | US20050142606 Determination of ions using ion-sensitive enzymes |
| 06/30/2005 | US20050142603 Method for producing a protein by culturing in culture medium a host cell transfected with a vector comprising a nucleic acid having the given nucleotide sequence; treatment of myocardial necrosis or ischemia reperfusion injuries; gene therapy; inhibits cell death associated with hypoxia, apoptosis |
| 06/30/2005 | US20050142601 Nucleic acids encoding an enediyne polyketide synthase complex |
| 06/30/2005 | US20050142594 DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer |
| 06/30/2005 | US20050142592 Nucleotide sequences coding proteins for use in diagnosis and treatment of tumors; prostate cancer antigen diagnostic marker 1 (PCADM-1) |
| 06/30/2005 | US20050142588 Nucleotide sequences coding sodium/bile co-transport protein for use in diagnosis, prevention and treatment of cell proliferative; pharmacogenomics |
| 06/30/2005 | US20050142587 Mammalian proteins designated Dendritic Cell Specific Transmembrane Protein (DC-STAMP) and DNAX Surface Protein (DSP-1) and their biological activities; useful in regulation, activation, development, differentiation, and function of various cell types, including hematopoietic cells |
| 06/30/2005 | US20050142572 Compositions, splice variants and methods relating to lung specific nucleic acids and proteins |
| 06/30/2005 | US20050142566 Sperm-specific cation channel, catSper2, and uses therefor |
| 06/30/2005 | US20050142561 Intracellular signaling pathways in diabetic subjects |
| 06/30/2005 | US20050142558 Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof |
| 06/30/2005 | US20050142557 Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
| 06/30/2005 | US20050142552 Susceptibility locus for schizophrenia |
| 06/30/2005 | US20050142550 Increased copy number of a nucleic acid linked to a reporter nucleic acid; screen cells for increased expression of a polypeptide derived from the nucleic acid, and related cell |
| 06/30/2005 | US20050142548 Allelic variants of grp50 |
| 06/30/2005 | US20050142546 Assays for identifying modulators of rhomboid polypeptides |
| 06/30/2005 | US20050142538 Viral receptor protein |
| 06/30/2005 | US20050142254 Composition for degrading aflatoxins and other toxic substances |
| 06/30/2005 | US20050142183 Expressing by means of a eukaryotic or prokaryotic vector, in which a nucleic acid coding for the mistletoe lectin polypeptide according to the usual genetic code or the fragment thereof is cloned in a suitable heterologous eukaryotic or prokaryotic host |
| 06/30/2005 | US20050142164 A bone morphogenetic protein, collagen, a shapable porous carrier body, and growth factors; a modified guanidinium hydrochloride extraction method, impregnation on a bioceramic carrier; improved storage stability |
| 06/30/2005 | US20050142151 Live attenuated vaccines against brucellosis and infection by other diseases; trans complementation of the Brucella wboA gene is used to maintain an expression vector in an attenuated Brucella host cell in a vaccinee; heterologous antigens can be expressed using this Brucella platform |
| 06/30/2005 | US20050142149 Virulence genes and proteins, and their use |
| 06/30/2005 | US20050142148 e.g. include antigenic gene product of another virus, such as influenza virus, respiratory syncytial virus, human metapneumovirus and avian pneumovirus; respiratory tract infections |
| 06/30/2005 | US20050142146 Vaccine; against Chlamydia pneumonia; therapy, prevention of infections, |
| 06/30/2005 | US20050142145 Derivatives of choline binding proteins for vaccines |
| 06/30/2005 | US20050142144 Epitope sequences |
| 06/30/2005 | US20050142142 recombinant T cell receptor ligand (RTL) for use treating autoimmune diseases |
| 06/30/2005 | US20050142140 Immunoadhesin comprising a glycoprotein VI domain |
| 06/30/2005 | US20050142138 Endothelial cell expression patterns |
| 06/30/2005 | US20050142132 Prevention and treatment of amyloidogenic disease |
| 06/30/2005 | US20050142125 Process for the preparation of protease inhibitor using novel alkalothermophilic Bacillus sp |
| 06/30/2005 | US20050142120 Cells expressing anti-Fc receptor binding components |
| 06/30/2005 | US20050142112 Administering recombinant adenoviral vector comprising a nucleic acid encoding p53 tumor suppressor protein; gene expression; contacting cells polyprenyl-protein transferase inhibitor FPT39; breast, colorectal, pancreatic, or prostate gland cancer treatment; antitumor and antimetastasis agents |
| 06/30/2005 | US20050142108 Methods of modulating cytokine activity; related reagents |
| 06/30/2005 | US20050142107 Use of IL-6-type cytokines for maturation of oocytes |
| 06/30/2005 | US20050142106 Mutant interleukin-2 (IL-2) polypeptides |
| 06/30/2005 | US20050142103 Mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood by administration of an inhibitor of GTPases such as Rac1 and Rac2 alone or in combination; specifically, methods are disclosed for mobilizing hematopoietic stem cells into subject's peripheral blood; treating cancer, anemia |
| 06/30/2005 | US20050142098 Polyoxyethylene glycol conjugated neublastin polypeptide dimers; exhibit prolonged bioavailability |
| 06/30/2005 | US20050142062 Novel method of diagnosing and treating gliomas |
| 06/30/2005 | DE10260929B4 Verfahren zur Kontrolle von auf mikrobieller Interaktion beruhenden Vorgängen Control procedures based on microbial interaction processes |
| 06/30/2005 | CA2588965A1 Novel chimeric plasminogen activators and their pharmaceutical use |
| 06/30/2005 | CA2560045A1 Methods and compositions comprising bacteriophage nanoparticles |
| 06/30/2005 | CA2551039A1 Analogues of glp-1 |
| 06/30/2005 | CA2550695A1 Glp-1 pharmaceutical compositions |
| 06/30/2005 | CA2550694A1 Quinoa protein concentrate, production and functionality |
| 06/30/2005 | CA2550581A1 Antimicrobial composition comprising a peptide derived from k-casein and a divalent cation |
| 06/30/2005 | CA2550108A1 Active immunization against clostridium difficile disease |
| 06/30/2005 | CA2550058A1 Pharmaceutical composition comprising a tgf-beta2 antisense oligonucleotide and a chemotherapeutic |
| 06/30/2005 | CA2550056A1 Plants having modified yield, and method for making the same comprising increased expression of a growth related ubx (grubx) protein |
| 06/30/2005 | CA2550050A1 Novel glp-1 analogues linked to albumin-like agents |
| 06/30/2005 | CA2550028A1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 06/30/2005 | CA2549884A1 Cytokine binding domains |
| 06/30/2005 | CA2549878A1 Glycosylation-deficient hepatocyte growth factor |
| 06/30/2005 | CA2549582A1 Novel glp-1 compounds |
| 06/30/2005 | CA2549573A1 Dna sequence, and recombinant preparation of group 4 major allergens from cereals |
| 06/30/2005 | CA2549529A1 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 06/30/2005 | CA2549523A1 Cytochrome c protein and assay |
| 06/30/2005 | CA2549303A1 Novel sodium channel |
| 06/30/2005 | CA2549052A1 Isozyme-specific antagonists of protein kinase c |
| 06/30/2005 | CA2548792A1 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 06/30/2005 | CA2548784A1 Frozen confectionery product comprising ice structuring proteins |
| 06/30/2005 | CA2548769A1 Ztnf 12, a tumor necrosis factor |
| 06/30/2005 | CA2548585A1 Treatment of viral infections |
| 06/30/2005 | CA2548349A1 P ef-tu expression units |
| 06/30/2005 | CA2548347A1 Methods for generating immunity to antigen |
| 06/30/2005 | CA2548338A1 Ip-10 antibodies and their uses |
| 06/30/2005 | CA2548306A1 Pgro expression units |
| 06/30/2005 | CA2548285A1 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity |
| 06/30/2005 | CA2548282A1 Methods and compositions for inhibiting c-met dimerization and activation |
| 06/30/2005 | CA2547792A1 Gene variants coding for proteins from the metabolic pathway of fine chemicals |
| 06/30/2005 | CA2547765A1 Yeast strains with improved fructose fermentation capacity |
| 06/30/2005 | CA2547635A1 A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 |
| 06/30/2005 | CA2545671A1 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 06/29/2005 | EP1548118A2 Complementary adenoviral vector systems and cell lines |
| 06/29/2005 | EP1548117A1 Rice regulatory sequences for gene expression in defined wheat tissue |
| 06/29/2005 | EP1548107A1 Chromoprotein and fluoroproteins |
| 06/29/2005 | EP1548106A1 Human-origin proteins forming domain and use thereof |
| 06/29/2005 | EP1548105A1 Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same |
| 06/29/2005 | EP1548100A1 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by Wnt factors |
| 06/29/2005 | EP1548032A1 Kdr peptides and vaccines comprising the same |
| 06/29/2005 | EP1548031A1 Nature-identical erythropoietin |
| 06/29/2005 | EP1548030A1 Use of lectin library for distinguishing glycoproteins or cells, diagnosing serum or cells, or fractionating glycoproteins or cells |
| 06/29/2005 | EP1548029A2 Peptid- and peptide mimetic derivatives having integrin inhibitor properties III |
| 06/29/2005 | EP1548028A1 Substituted type peptides of wt1 |
| 06/29/2005 | EP1547618A1 Drug for auditory dysfunction |
| 06/29/2005 | EP1547609A1 Embryo implantation inhibitor |
| 06/29/2005 | EP1547451A2 Cell adhesion resisting surfaces |
| 06/29/2005 | EP1546726A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 06/29/2005 | EP1546725A1 Regulation of human p2y15 g protein-coupled receptor |
| 06/29/2005 | EP1546717A1 Analyzing nerve cell damage |
| 06/29/2005 | EP1546703A2 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 06/29/2005 | EP1546702A2 Transgenic cancer models in fish |